CervoMed Inc. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/c2e53493-405f-4bd1-bda5-905ae6f5a908/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $4.0M | 2025-01-01 – 2025-12-31 | evidence 0001437749-26-008259 |
| FY 2024 | $9.7M | 2024-01-01 – 2024-12-31 | evidence 0001437749-25-007829 |
| FY 2023 | $7.1M | 2023-01-01 – 2023-12-31 | evidence 0001437749-24-010064 |
| FY 2022 | $0 | 2022-01-01 – 2022-12-31 | evidence 0001437749-24-010064 |
| FY 2013 | $71.7k | 2013-01-01 – 2013-12-31 | evidence 0001019687-14-001523 |
| FY 2012 | $374.5k | 2012-01-01 – 2012-12-31 | evidence 0001019687-14-001523 |
| FY 2011 | $570.5k | 2011-01-01 – 2011-12-31 | evidence 0001019687-13-001483 |
| FY 2010 | $40.2k | 2010-01-01 – 2010-12-31 | evidence 0001019687-12-001932 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).